A ripk3-independent role of mlkl in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma

HIGHLIGHTS

• who: Xifei Jiang from the underwent hepatectomy from April , to September , at the Department of Liver Surgery, Zhongshan Hospital, Fudan University (Shanghai, China), was used in the present studyThe study obtained ethical approval from the Institutional Review Board of Zhongshan Hospital (B2021-611) and complied with the standards of the Declaration of Helsinki. Informed consent was received from each patient before the research. All the patients in the Zhongshan cohort of our study received a histopathological confirmation of HCC after hepatectomy. Every patient adopted a standardized follow-up protocol until December, . Briefly, patients underwent follow-up visits . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.